Type 2 diabetes is a metabolic disorder arising from a complex interaction between genes and the environment. Classes of medications including sulfonylureas, meglitinides, biguanides ...

Byram Healthcare, a leader in home-based care and part of the Owens & Minor (NYSE: OMI) family, recently launched ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...

GLP-1 agonist medications, originally designed to manage type 2 diabetes, are now FDA-approved for weight management. Klarity connects you with healthcare providers to create a personalized ...